Resveratrol Enhances Antitumor Activity of TRAIL in Prostate Cancer Xenografts through Activation of FOXO Transcription Factor

Suthakar Ganapathy(The University of Texas Health Science Center at San Antonio), Rohit Srivastava(The University of Texas Health Science Center at Tyler)
PLoS ONE
December 28, 2010
10.1371/journal.pone.0015627
Cited by 133

Related Papers

Resveratrol Inhibits Pancreatic Cancer Stem Cell Characteristics in Human and KrasG12D Transgenic Mice by Inhibiting Pluripotency Maintaining Factors and Epithelial-Mesenchymal Transition
|PLoS ONE|2011|301
Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer
|International Journal of Oncology|2007|235
The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition
|Journal of Molecular Signaling|2010|221
Biomolecular characterization of exosomes released from cancer stem cells: Possible implications for biomarker and treatment of cancer
|Oncotarget|2014|192
PI3K/AKT/mTOR and sonic hedgehog pathways cooperate together to inhibit human pancreatic cancer stem cell characteristics and tumor growth
|Oncotarget|2015|160